Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Baxter
Teva
Argus Health
Boehringer Ingelheim
Fuji
Moodys
Deloitte
Express Scripts

Generated: May 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017783

« Back to Dashboard

NDA 017783 describes GLUCOTROL, which is a drug marketed by Pfizer and is included in two NDAs. It is available from two suppliers. There is one patent protecting this drug. Additional details are available on the GLUCOTROL profile page.

The generic ingredient in GLUCOTROL is glipizide. There are eighteen drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the glipizide profile page.
Summary for 017783
Tradename:GLUCOTROL
Applicant:Pfizer
Ingredient:glipizide
Patents:0
Therapeutic Class:Blood Glucose Regulators
Formulation / Manufacturing:see details
Pharmacology for NDA: 017783
Ingredient-typeSulfonylurea Compounds
Medical Subject Heading (MeSH) Categories for 017783
Suppliers and Packaging for NDA: 017783
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
GLUCOTROL glipizide TABLET;ORAL 017783 NDA Roerig 0049-4110 N 0049-4110-66
GLUCOTROL glipizide TABLET;ORAL 017783 NDA Roerig 0049-4120 N 0049-4120-66

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:May 8, 1984TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:May 8, 1984TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength2.5MG
Approval Date:May 11, 1993TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
AstraZeneca
Dow
Fish and Richardson
Deloitte
Boehringer Ingelheim
Moodys
McKesson
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.